E133 – Prescribing for patients on antiretrovirals

E133 – Prescribing for patients on antiretrov...

Up next

E222 - Acne vulgaris: a clinical update

Jo Cheah talks to dermatologist Belinda Welsh about her article on acne vulgaris. Belinda discusses the chronic inflammatory nature of acne and the substantial psychosocial burden if it is inadequately untreated. She discusses the different treatments available and shares practic ...  Show more

E221 - Antibiotic prophylaxis for dental procedures: an update

Dhineli Perera chats with dentist Smitha Sukumar about the use of antibiotic prophylaxis for dental procedures. They discuss the updated recommendations in Therapeutic Guidelines: Oral and Dental, including when antibiotic prophylaxis is indicated and considerations for immunocom ...  Show more

Recommended Episodes

S2 Episode 1: Anticipating and Managing Drug Interactions: Pharmacokinetics of Long-Acting HIV Treatment and Prevention Formulations
Medscape InDiscussion: HIV

Drs Michael S. Saag and Charles W. Flexner discuss the mechanisms of drug-drug interactions and the promise and limitations of longer-acting HIV therapeutics for both treatment and prevention. Relevant disclosures can be found with the episode show notes on Medscape ( https://www. ...  Show more

Why Medicaid Matters: Why Protecting Medicaid Matters for People with HIV
Let's Talk ID

Anna Person, MD discusses threats to the Medicaid program and how they could impact people with HIV with Kate McManus, MD, MSc, FIDSA, Associate Professor of Medicine at the University of Virginia in the Division of Infectious Diseases and International Health and Amy Killelea, J ...  Show more

Top 200 Drugs - Antifungals, Antivirals
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antifungals and antivirals: fluconazole, itraconazole, ketoconazole, oseltamivir, acyclovir, valacyclovir, docosanol, terbinafine, and clotrimazole or miconazole. 

Preventing HIV with antiretrovirals - Trip Gulick, MD/ Trip Gulick, MD
IDBR Infectious Disease Board Review

A 58-year-old HIV- negative gay man is evaluated for PrEP. His past medical history is notable for hypertension, treated for over 10 years with an ACE inhibitor. He is asymptomatic and weighs 145 lbs. He is sexually active with multiple partners but “usually” practices safe sex. ...  Show more